Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
West Coast Retina Medical Group, Inc.
With
Genentech, Inc.
Age
Any age
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Ability to provide written informed consent for participation in this study
Subjects diagnoses of neovascular AMD who are on a monthly anti-VEGF regimen (have had \>10 or more ranibizumab and/or bevacizumab injections within the last year) and who still have intra-retinal or subretinal fluid as confirmed by the Investigator
You may not be if
Subjects with a Pigment Epithelial Detachment Exclusively
Subjects with Serous Pigment Epithelial Detachments
Subjects with history of the following:
idiopathic polypoidal choroidal vasculopathy
pathologic degenerative myopia
central serous chorioretinopathy
familial drusen
adult onset foveal pattern dystrophy
Clareo Health | Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy
